Close Menu

The Washington Post tells the story of an Army medic and his father who took direct-to-consumer genetic test as a means of looking into the DTC industry. The Galls had their DNA looked at by both 23andMe and Decode and Timothy Gall, the medic, says that he found some of the results useful — such as a potential sensitivity to blood thinners — but others were baffling.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Bloomberg reports AstraZeneca may conduct another study of its candidate SARS-CoV-2 vaccine after dosing error.

Moderna is applying for an Emergency Use Authorization for its coronavirus vaccine, according to the New York Times.

The National Health Service is to conduct a trial of Grail's blood-based screening test for cancer.

In PLOS this week: somatic mutation patterns of glioblastomas among Lebanese patients, phenome-wide study using UK Biobank data, and more.